Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial
Hundertmark MJ, Adler A, Antoniades C, et al.
Circulation. Pub. online 18 Apr 2023.
Leggi